|
|
|
市場調査レポート
米国の救命救急患者モニタリング装置市場：2009年
US MARKETS FOR CRITICAL CARE PATIENT MONITORING 2009
|
Abstract
The US critical care patient monitoring market, which comprises vital signs,
hemodynamic, neurological, and neonatal electroencephalography (EEG)
monitoring, declined very modestly from 2007 to 2008, mainly resulting from
deferred capital equipment purchases in hospitals across the country.
Table of Contents
LIST OF EXHIBITS
EXECUTIVE SUMMARY
METHODOLOGY
1.0 US CRITICAL CARE PATIENT MONITORING MARKET
- 1.1 Market Overview
- 1.2 Market Analysis
- 1.2.1 Key Report Updates
- 1.2.2 Introduction
- Critical Care Environment
- Critical Care Patient Monitoring
- 1.2.3 Device Types
- Vital Signs Monitors
- Hemodynamic Monitors
- Neurological Monitors
- Neonatal Electroencephalography Monitors
- 1.2.4 Economic Assumptions for the Forecast Period
- 1.2.5 Market Forecast
- 1.2.5.1 Vital Signs Monitoring Market
- 1.2.5.2 Hemodynamic Monitoring Market
- 1.2.5.3 Neurological Monitoring Market
- 1.2.5.4 Neonatal Electroencephalography Monitoring Market
- 1.2.6 Market Drivers and Limiters
- 1.2.6.1 Market Drivers
- 1.2.6.2 Market Limiters
- 1.3 Competitive Analysis
2.0 VITAL SIGNS MONITORING MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Market Definitions
- 2.2.1.1 Spot - Check and Low - Acuity Monitors
- 2.2.1.2 Intermediate and High - Acuity Monitors
- 2.2.1.3 Patient - Worn Monitors
- 2.2.2 Market Forecast
- 2.2.2.1 Spot - Check and Low - Acuity Monitoring Market
- 2.2.2.2 Intermediate and High - Acuity Monitoring Market
- 2.2.2.3 Patient - Worn Monitor Market
- 2.2.3 Market Drivers and Limiters
- 2.2.3.1 Market Drivers
- 2.2.3.2 Market Limiters
- 2.3 Competitive Analysis
3.0 HEMODYNAMIC MONITORING MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Market Definitions
- 3.2.1.1 Invasive Hemodynamic Monitoring
- 3.2.1.2 Minimally Invasive Hemodynamic Monitoring
- 3.2.1.3 Noninvasive Hemodynamic Monitoring
- 3.2.1.4 Methods of Hemodynamic Monitoring
- Thermodilution
- Arterial Pressure Waveform Analysis
- Doppler Ultrasonography
- Impedance Cardiography
- Bioreactance
- Fick Partial Rebreathing
- 3.2.2 Market Forecast
- 3.2.2.1 Invasive Hemodynamic Monitoring Market
- 3.2.2.2 Minimally Invasive Hemodynamic Monitoring Market
- 3.2.2.3 Noninvasive Hemodynamic Monitoring Market
- 3.2.3 Market Drivers and Limiters
- 3.2.3.1 Market Drivers
- 3.2.3.2 Market Limiters
- 3.3 Competitive Analysis
4.0 NEUROLOGICAL MONITORING MARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Market Definition
- 4.2.1.1 Intracranial Pressure Monitoring
- 4.2.1.2 Advanced Neurological Monitoring
- Near - Infrared Spectroscopy
- Cerebral Blood Flow Monitoring
- Metabolic Monitoring
- 4.2.2 Market Forecast
- 4.2.2.1 Intracranial Pressure Monitoring Market
- 4.2.2.2 Advanced Neurological Monitoring Market
- 4.2.3 Market Drivers and Limiters
- 4.2.3.1 Market Drivers
- 4.2.3.2 Market Limiters
- 4.3 Competitive Analysis
- 4.3.1 Emerging Competitors
5.0 NEONATAL EEG MONITORING MARKET
- 5.1 Market Overview
- 5.2 Market Analysis
- 5.2.1 Market Definitions
- 5.2.1.1 Electroencephalography
- 5.2.1.2 Amplitude - Integrated Electroencephalography
- 5.2.1.3 Neonatal Electroencephalography Monitors
- 5.2.1.4 Neonatal Electroencephalography Sensors
- 5.2.2 Market Forecast
- 5.2.2.1 Neonatal Electroencephalography Monitor Market
- 5.2.2.2 Neonatal Electroencephalography Sensor Market
- 5.2.3 Market Drivers and Limiters
- 5.2.3.1 Market Drivers
- 5.2.3.2 Market Limiters
- 5.3 Competitive Analysis
- 5.3.1 Emerging Competitors
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: SUPPLEMENTAL EXHIBITS
List of Exhibits
EXECUTIVE SUMMARY VIII
- Exhibit 1: Critical Care Patient Monitoring Market, by Segment, as a % of
Total, US, 2007 - 2013 VIII
- Exhibit 2: Vital Signs Monitoring Market, US (US$), 2007 - 2013 IX
- Exhibit 3: Hemodynamic Monitoring Market, by Segment, as a % of Total, US,
2007 - 2013 X
- Exhibit 4: Neurological Monitoring Market, by Segment, as a % of Total,
US, 2008 and 2013 XI
- Exhibit 5: Neonatal EEG Monitoring Market, US (US$), 2007 - 2013 XII
- Exhibit 6: Leading Competitors in the Critical Care Patient Monitoring
Market, US, 2008 XIII
CHAPTER 1: US CRITICAL CARE PATIENT MONITORING MARKET 1
- Exhibit 7: Critical Care Patient Monitoring Market, US (US$), 2007 - 2013
1
- Exhibit 8: Key Report Updates, 2009 2
- Exhibit 9: Critical Care Patient Monitoring Market, by Segment, US (US$),
2007 - 2013 (Graphical Format) 9
- Exhibit 10: Critical Care Patient Monitoring Market, by Segment, US (US$),
2007 - 2013 (Tabular Format) 10
- Exhibit 11: Critical Care Patient Monitoring Market Growth, by Segment,
US, 2008 - 2013 10
- Exhibit 12: Critical Care Patient Monitoring Market, by Segment, as a % of
Total, US, 2007 - 2013 11
- Exhibit 13: Drivers and Limiters of the Critical Care Patient Monitoring
Market, US 14
- Exhibit 14: Leading Competitors in the Critical Care Patient Monitoring
Market, as a % of Total, US, 2008 19
- Exhibit 15: Leading Competitors in the Critical Care Patient Monitoring
Market, by Segment, as a % of Total, US, 2008 20
CHAPTER 2: VITAL SIGNS MONITORING MARKET 23
- Exhibit 16: Vital Signs Monitoring Market, US (US$), 2007 - 2013
(Graphical Format) 23
- Exhibit 17: Vital Signs Monitoring Market, by Segment, US (US$), 2007 -
2013 (Graphical Format) 26
- Exhibit 18: Vital Signs Monitoring Market, by Segment, US (US$), 2007 -
2013 (Tabular Format) 28
- Exhibit 19: Vital Signs Monitoring Market Growth, by Segment, US, 2008 -
2013 29
- Exhibit 20: Vital Signs Monitoring Market, by Segment, as a % of Total,
US, 2007 - 2013 30
- Exhibit 21: Drivers and Limiters of the Vital Signs Monitoring Market, US
31
- Exhibit 22: Leading Competitors in the Vital Signs Monitoring Market, as a
% of Total, US, 2008 (Graphical Format) 35
- Exhibit 23: Leading Competitors in the Vital Signs Monitoring Market, as a
% of Total, US, 2008 (Tabular Format) 36
CHAPTER 3: HEMODYNAMIC MONITORING MARKET 38
- Exhibit 24: Hemodynamic Monitoring Market, by Segment, US (US$), 2007 -
2013 38
- Exhibit 25: Techniques Used to Measure Cardiac Output 43
- Exhibit 26: Hemodynamic Monitor Market, by Segment, US (US$), 2007 - 2013
46
- Exhibit 27: Hemodynamic Monitor Market Growth, by Segment, US, 2008 - 2013
47
- Exhibit 28: Hemodynamic Sensor Market, by Segment, US (US$), 2007 - 2013
48
- Exhibit 29: Hemodynamic Sensor Market Growth, by Segment, US, 2008 - 2013
49
- Exhibit 30: Hemodynamic Monitoring Market, by Segment, US (US$), 2007 -
2013 50
- Exhibit 31: Hemodynamic Monitoring Market, by Segment, as a % of Total,
US, 2008 and 2013 51
- Exhibit 32: Drivers and Limiters of the Hemodynamic Monitoring Market, US
52
- Exhibit 33: Leading Competitors in the Hemodynamic Monitoring Market, as a
% of Total, US, 2008 (Graphical Format) 56
- Exhibit 34: Leading Competitors in the Hemodynamic Monitoring Market, as a
% of Total, US, 2008 (Tabular Format) 57
CHAPTER 4: NEUROLOGICAL MONITORING MARKET 61
- Exhibit 35: Neurological Monitoring Market, by Segment, US (US$), 2007 -
2013 (Graphical Format) 61
- Exhibit 36: Neurological Monitoring Market, by Segment, US (US$), 2007 -
2013 67
- Exhibit 37: Neurological Monitoring Market Growth, by Segment, US, 2008 -
2013 68
- Exhibit 38: Neurological Monitoring Market, by Segment, US (US$), 2007 -
2013 69
- Exhibit 39: Neurological Monitoring Market, by Segment, as a % of Total,
US, 2008 and 2013 70
- Exhibit 40: Drivers and Limiters of the Neurological Monitoring Market, US
71
- Exhibit 41: Leading Competitors in the Neurological Monitoring Market, as
a % of Total, US, 2008 75
- Exhibit 42: Leading Competitors in the Neurological Monitoring Market, by
Segment, as a % of Total, US, 2008 76
CHAPTER 5: NEONATAL EEG MONITORING MARKET 79
- Exhibit 43: Neonatal EEG Monitoring Market, US (US$), 2007 - 2013 79
- Exhibit 44: Neonatal EEG Monitoring Market, by Segment, US (US$), 2007 -
2013 (Graphical Format) 82
- Exhibit 45: Neonatal EEG Monitoring Market, by Segment, US (US$), 2007 -
2013 (Tabular Format) 84
- Exhibit 46: Neonatal EEG Monitoring Market Growth, by Segment, US, 2008 -
2013 85
- Exhibit 47: Neonatal EEG Monitoring Market, by Segment, as a % of Total,
US, 2007 - 2013 85
- Exhibit 48: Drivers and Limiters of the Neonatal EEG Monitoring Market, US
86
- Exhibit 49: Leading Competitors in the Neonatal EEG Monitoring Market, as
a % of Total, US, 2008 (Graphical Format) 89
- Exhibit 50: Leading Competitors in the Neonatal EEG Monitoring Market, as
a % of Total, US, 2008 (Tabular Format) 89
APPENDIX B: SUPPLEMENTAL EXHIBITS 93
- Exhibit 51: Critical Care Patient Monitoring Market, by Segment, as a % of
Total, US, 2007 - 2013 (Detailed Format) 93
- Exhibit 52: Vital Signs Monitoring Market, US (US$), 2007 - 2013 (Detailed
Format) 94
- Exhibit 53: Hemodynamic Monitoring Market, by Segment, as a % of Total,
US, 2007 - 2013 (Detailed Format) 94
- Exhibit 54: Neurological Monitoring Market, by Segment, as a % of Total,
US, 2008 and 2013 (Detailed Format) 95
- Exhibit 55: Neonatal EEG Monitoring Market, US (US$), 2007 - 2013
(DetailedFormat) 95
|
 |
